Welcome to Flacks & Wong.
Your corporate law experts.

A snapshot of what we do

We advise listed and private companies, private equity funds, entrepreneurs, and start-ups on buying, selling and investing in businesses, raising capital in the public and private markets and on their important commercial transactions.

We provide strategic, governance and compliance advice to boards of directors, senior executives and corporates.

We advise on general corporate and commercial matters.

We are a specialist corporate law firm based in Auckland, New Zealand.

Our directors, David Flacks and Daniel Wong, together have more than 50 years’ top‑tier domestic and international experience across all areas of corporate and commercial law including:

  • Buying, selling and investing in businesses, including Takeovers Code transactions
  • Capital raisings, including equity crowdfunding, IPOs and start-up funding
  • Strategic, governance and compliance advice
  • Resolving board, and shareholder, disputes and ownership issues
  • Joint ventures, shareholders’ arrangements and other commercial transactions
  • General corporate and commercial law advice

Although we specialise in corporate law, we regularly access other areas of expertise as required. We take responsibility for project managing those other experts so that you have a single point of contact

As well as our corporate law expertise:

  • We are admired for our "attentiveness and business-orientation", and described as "very commercial in their approach" (Chambers Asia-Pacific 2019
  • We are described by clients as "very diligent and responsive with top-notch business acumen" and "equally adept across all sizes of transaction" (The Legal 500 Asia Pacific 2019)
  • We are highly respected for our long-standing track record in completing M&A, and capital markets, transactions
  • We have a reputation for providing clear, and concise, solutions-focused advice
  • We have deep relationships with New Zealand capital markets regulators and participants
  • We offer access to senior, experienced lawyers only

Our expertise is independently recognised:

  • Leading firm for Corporate/Commercial in Chambers Asia-Pacific 2019
  • David Flacks and Daniel Wong are each individually ranked for Corporate/Commercial in Chambers Asia-Pacific 2019
  • Leading firm for Corporate and M&A in The Legal 500 Asia Pacific 2019
  • Daniel Wong is in the elite tier of leading individuals for Corporate and M&A in The Legal 500 Asia Pacific 2019
  • Finalist for "Boutique Law Firm of the Year" and "Deal Team of the Year (<100 Lawyers)" at each of the last two New Zealand Law Awards (2018 and 2017)
  • Finalist for "Mid-Market Deal of the Year" at the New Zealand Law Awards 2017
  • Winner of “Mid-Market Deal of the Year” at the New Zealand Law Awards 2016
  • L500 2019
  • 2016 - Mid Market

The directors of Flacks & Wong have advised:

  • Serko on its US share-for-share acquisition of InterplX
  • Impact Enterprise Fund on its investment in Melon Health
  • Archipro, the Dust Palace and Zeffer Cider on their respective equity crowdfunding campaigns
  • Appliance Shed on the sale of its business to Noel Leeming
  • Keytone Dairy on its IPO in New Zealand and Australia and its listing on the ASX
  • Oyster Property Group on its joint venture with KKR to acquire the Central Park Corporate Centre
  • Serko on the establishment of its non-executive director fixed trading share plan
  • Genesis Youth Trust on its (and New Zealand's second) offer of social bonds
  • APM Workcare on its (and New Zealand's first) offer of social bonds
  • The vendors on the sale of Compac Sorting Equipment to Tomra Systems
  • Coretex on its acquisition (by way of merger) of Imarda and International Telematics, and the subsequent subscription by Milford of equity into Coretex
  • Teva Pharmaceuticals on the application of New Zealand's overseas investment regime to its acquisition of Mylan
  • Orion Health on its IPO in New Zealand and Australia and its listing on the NZX Main Board and the ASX
  • The Better Bar Group of companies on the sale of their business to Veritas Investments
  • The Commonwealth of Australia on its IPO of Medibank Private in New Zealand
  • The principal vendors on the sale of Interpac Packaging to Huhtamaki
  • Serko on its IPO in New Zealand and Australia and its listing on the NZX Main Board
  • Rex Bionics on its reverse listing on the AIM market
  • Bauer Media Group on its acquisition of certain magazine titles from NZME.
  • AIM-listed Endace on its public takeover offer by Emulex Corporation

Contact us

Feel free to give one of us a call and let’s chat over a coffee. We don’t charge for an initial discussion and we’ll be upfront on what we think the issues are and whether we can assist.

Contact details for our lawyers appear on the ‘Meet the team’ section above. Alternatively, please contact us by completing this form.

Level 5, Shortland Chambers Building
70 Shortland Street
PO Box 591
Auckland 1140
New Zealand

Thank you for contacting us. We’ll be in touch with you shortly.

There was a problem communicating with the server. Please check your fields, and try again in a soon.